Screening neuroprotective agents
Screening neuroprotective agents is a crucial step in the pursuit of treatments for neurodegenerative diseases. By screening compounds with different mechanisms of action, researchers can identify new therapeutic targets and ultimately develop new drugs that can improve the quality of life of patients.
